These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 11848724)

  • 21. COPD in individuals with the PiMZ alpha-1 antitrypsin genotype.
    Al Ashry HS; Strange C
    Eur Respir Rev; 2017 Dec; 26(146):. PubMed ID: 29070580
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Health status and lung function in the Swedish alpha 1-antitrypsin deficient cohort, identified by neonatal screening, at the age of 37-40 years.
    Piitulainen E; Mostafavi B; Tanash HA
    Int J Chron Obstruct Pulmon Dis; 2017; 12():495-500. PubMed ID: 28203073
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Granularity of
    Gupta N; Gaudreault N; Thériault S; Li PZ; Henry C; Kirby M; Maltais F; Tan W; Bourbeau J; Bossé Y;
    Eur Respir J; 2020 Oct; 56(4):. PubMed ID: 32482783
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surfactant protein-B 121ins2 heterozygosity, reduced pulmonary function, and chronic obstructive pulmonary disease in smokers.
    Baekvad-Hansen M; Dahl M; Tybjaerg-Hansen A; Nordestgaard BG
    Am J Respir Crit Care Med; 2010 Jan; 181(1):17-20. PubMed ID: 19833825
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glutathione S-transferase P1 and lung function in patients with alpha1-antitrypsin deficiency and COPD.
    Rodriguez F; de la Roza C; Jardi R; Schaper M; Vidal R; Miravitlles M
    Chest; 2005 May; 127(5):1537-43. PubMed ID: 15888825
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SERPINA1 PiZ and PiS heterozygotes and lung function decline in the SAPALDIA cohort.
    Thun GA; Ferrarotti I; Imboden M; Rochat T; Gerbase M; Kronenberg F; Bridevaux PO; Zemp E; Zorzetto M; Ottaviani S; Russi EW; Luisetti M; Probst-Hensch NM
    PLoS One; 2012; 7(8):e42728. PubMed ID: 22912729
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Frequency of alpha-1 antitrypsin deficiency and unexpected results in COPD patients in Turkey; rare variants are common.
    Çörtük M; Demirkol B; Arslan MA; İlhan U; Kalkan YE; Turan D; Gül Ş; Çınarka H; Baydili KN; Çetinkaya E
    Turk J Med Sci; 2022 Oct; 52(5):1478-1485. PubMed ID: 36422500
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alpha-1 Antitrypsin Deficiency and Tobacco Smoking: Exploring Risk Factors and Smoking Cessation in a Registry Population.
    Franciosi AN; Alkhunaizi MA; Woodsmith A; Aldaihani L; Alkandari H; Lee SE; Fee LT; McElvaney NG; Carroll TP
    COPD; 2021 Feb; 18(1):76-82. PubMed ID: 33557645
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The prevalence of alpha-antitrypsin heterozygotes (Pi MZ) in patients with obstructive pulmonary disease.
    Shigeoka JW; Hall WJ; Hyde RW; Schwartz RH; Mudholkar GS; Speers DM; Lin CC
    Am Rev Respir Dis; 1976 Dec; 114(6):1077-84. PubMed ID: 1087539
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determinants of airflow obstruction in severe alpha-1-antitrypsin deficiency.
    Demeo DL; Sandhaus RA; Barker AF; Brantly ML; Eden E; McElvaney NG; Rennard S; Burchard E; Stocks JM; Stoller JK; Strange C; Turino GM; Campbell EJ; Silverman EK
    Thorax; 2007 Sep; 62(9):806-13. PubMed ID: 17389752
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alpha-1 Antitrypsin PiMZ Genotype Is Associated with Chronic Obstructive Pulmonary Disease in Two Racial Groups.
    Foreman MG; Wilson C; DeMeo DL; Hersh CP; Beaty TH; Cho MH; Ziniti J; Curran-Everett D; Criner G; Hokanson JE; Brantly M; Rouhani FN; Sandhaus RA; Crapo JD; Silverman EK;
    Ann Am Thorac Soc; 2017 Aug; 14(8):1280-1287. PubMed ID: 28380308
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetically increased antioxidative protection and decreased chronic obstructive pulmonary disease.
    Juul K; Tybjaerg-Hansen A; Marklund S; Lange P; Nordestgaard BG
    Am J Respir Crit Care Med; 2006 Apr; 173(8):858-64. PubMed ID: 16399992
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of alpha-1 antitrypsin high-risk variants in Mexican mestizo population and their association with lung function values.
    Pérez-Rubio G; Jiménez-Valverde LO; Ramírez-Venegas A; Camarena Á; Sansores RH; Flores-Trujillo F; Reséndiz-Hernández JM; Falfán-Valencia R
    Arch Bronconeumol; 2015 Feb; 51(2):80-85. PubMed ID: 25454901
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heterozygosity for E292V in ABCA3, lung function and COPD in 64,000 individuals.
    Bækvad-Hansen M; Nordestgaard BG; Dahl M
    Respir Res; 2012 Aug; 13(1):67. PubMed ID: 22866751
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alpha-1 Antitrypsin Deficiency in COPD Patients: A Cross-Sectional Study.
    Sorroche PB; Fernández Acquier M; López Jove O; Giugno E; Pace S; Livellara B; Legal S; Oyhamburu J; Saez MS
    Arch Bronconeumol; 2015 Nov; 51(11):539-43. PubMed ID: 25800328
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The protease inhibitor PI*S allele and COPD: a meta-analysis.
    Dahl M; Hersh CP; Ly NP; Berkey CS; Silverman EK; Nordestgaard BG
    Eur Respir J; 2005 Jul; 26(1):67-76. PubMed ID: 15994391
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clarifying the Risk of Lung Disease in SZ Alpha-1 Antitrypsin Deficiency.
    Franciosi AN; Hobbs BD; McElvaney OJ; Molloy K; Hersh C; Clarke L; Gunaratnam C; Silverman EK; Carroll TP; McElvaney NG
    Am J Respir Crit Care Med; 2020 Jul; 202(1):73-82. PubMed ID: 32197047
    [No Abstract]   [Full Text] [Related]  

  • 38. Variability of pulmonary function in alpha-1-antitrypsin deficiency: clinical correlates.
    Silverman EK; Pierce JA; Province MA; Rao DC; Campbell EJ
    Ann Intern Med; 1989 Dec; 111(12):982-91. PubMed ID: 2596778
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fifteen-year follow-up of pulmonary function in individuals heterozygous for the cystic fibrosis phenylalanine-508 deletion.
    Dahl M; Nordestgaard BG; Lange P; Tybjaerg-Hansen A
    J Allergy Clin Immunol; 2001 May; 107(5):818-23. PubMed ID: 11344348
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characteristics and outcomes of chronic obstructive pulmonary disease in never smokers in Denmark: a prospective population study.
    Thomsen M; Nordestgaard BG; Vestbo J; Lange P
    Lancet Respir Med; 2013 Sep; 1(7):543-50. PubMed ID: 24461615
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.